期刊文献+

5种人细胞色素P450 2A13突变体的异源表达及其香豆素代谢活性 被引量:1

Heterogenous expression of five human cytochrome P450 2A13 mutants and their catalytic activities of coumarin
下载PDF
导出
摘要 目的重组表达人细胞色素P450(CYP)2A13突变体CYP2A13*2,CYP2A13*5,CYP2A13*6,CYP2A13*8和CYP2A13*9,并研究CYP2A13突变体与野生型CYP2A13(CYP2A13*1)对香豆素的代谢活性上的差异。方法通过点突变法构建各CYP2A13突变体。用杆状病毒表达系统制备含各突变体c DNA的重组病毒,并将其与含人源还原型烟酰胺腺嘌呤二核苷磷酸P450氧化还原酶(POR,野生型)的重组杆状病毒共转染昆虫草地夜蛾细胞(sf9),共表达CYP2A13突变体和POR重组蛋白。将表达产物制备成微粒体与香豆素(0.25~25μmol·L-1)体外孵育30 min,高效液相色谱法测定各重组酶对香豆素的代谢活性。结果Western蛋白印迹结果表明,各重组酶在sf9细胞中得到了表达。体外代谢实验显示,CYP2A13野生型及其突变体蛋白代谢香豆素在Km值上无显著差异,而在Vmax(mol·min-1·mol-1CYP)上,CYP2A13*2(0.58±0.05,P〈0.05)、CYP2A13*5(0.71±0.08,P〈0.01)、CYP2A13*6(0.84±0.09,P〈0.01)、CYP2A13*9(0.58±0.04,P〈0.05)等突变体与CYP2A13*1(0.33±0.06)相比有显著性差异,使得这4个突变体的代谢效率增加了40%~108%。结论体外成功表达了具有活性的CYP2A13*2,CYP2A13*5,CYP2A13*6,CYP2A13*8和CYP2A13*9重组蛋白。CYP2A13*2,CYP2A13*5,CYP2A13*6和CYP2A13*9等突变体的香豆素代谢活性明显高于CYP2A13*1。 OBJECTIVE To construct and express recombinant human P450 2A13 mutants CYP2A13*2, CYP2A13*5, CYP2A13*6, CYP2A13*8 and CYP2A13*9, and to determine the function- al consequences, if any, that CYP2A13 mutants might have on CYP2A13-catalysed coumarin metabo- lism. METHODS The wild-type CYP2A13 gene was used as template to obtain CYP2A13 mutants by site-directed mutation PCR. Bac-to-Bac Baculovirus expression system was employed to produce re- combinant baculovirus carrying cDNAs of CYP2A13 mutants. Spodoptera frugiperc/a 9 (Sf9) cells were co-infected with recombinant baculovirus of CYP2A13 mutants and human NADPH-P450 oxidoreduc- tase (POR, wildtype) to express CYP2A13 proteins. The microsome containing recombinant proteins was prepared and incubated with coumarin (0.25-25 μmol·L^-1) for 30 min. The coumarin 7-hydroxyl- ation activities of CYP2A13 mutants were determined by HPLC. RESULTS A single band of 56 ku was detected in the microsomes prepared from the Sf9 cells transfected with bacmids containing CYP2A13 cDNAs. CYP2A13 mutants and CYP2A13*1 had similar K,,values. However, the Vr~ values (mol- min-1. mo1-1 CYP) of CYP2A13*2 (0.58±0.05, P〈0.05), CYP2A13*5 (0.71±0.08, P〈0.01), CYP2A13*6 (0.84± 0.09, P〈 0.01) and CYP2A13*9 (0.58 ±0.04, P〈 0.05) were significantly higher those of CYP2A13*1 (0.33±0.06), which resulted in a 40%- 108% increase of catalytic efficiency. CONCLUSION CYP2A13*2, CYP2A13*5, CYP2A13*6, CYP2A13*8 and CYP2A13*9 with metabolic activities are successfully expressed using Bac-to-Bac baculovirus expression system. The results of coumarin metabolism show that the coumarin 7-hydroxylation activities of CYP2A13*2, CYP2A13*5, CYP2A13*6 and CYP2A13*9 are significantly higher than those of CYP2A13*1.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2015年第4期591-598,共8页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金(81273578) 国家科技重大专项基金(2012ZX09506001-004) 贵州省科技厅基金(黔科合J字[2013]2034号 贵州省科技厅基金(黔科合中药字[2013]5002号) 贵阳医学院大学生创新创业项目(201410660005)~~
关键词 细胞色素P450 CYP2A13 突变体 杆状病毒表达系统 香豆素 cytochrome P-450 CYP2A13 mutant baculovirus expression system coumarin
  • 相关文献

参考文献21

  • 1Castell JV,Donato MT,Gómez-Lechón MJ.Metabolism and bioactivation of toxicants in the lung.The in vitro cellular approach[J].Exp Toxicol Pathol,2005,57(Suppl 1):189-204.
  • 2Su T,Bao Z,Zhang QY,Smith TJ,Hong JY,Ding X.Human cytochrome P450 CYP2A13:predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen,4(-methylnitrosamino)-1(-3-pyridyl)-1-butanone[J].Cancer Res,2000,60(18):5074-5079.
  • 3Zhu LR,Thomas PE,Lu G,Reuhl KR,Yang GY,Wang LD,et al.CYP2A13 in human respiratory tissues and lung cancers:an immunohistochemical study with a new peptide-specific antibody[J].Drug Metab Dispos,2006,34(10):1672-1676.
  • 4He XY,Tang L,Wang SL,Cai QS,Wang JS,Hong JY.Efficient activation of aflatoxin B1 by cytochrome P450 2A13,an enzyme predominantly expressed in human respiratory tract[J].Int J Cancer,2006,118(11):2665-2671.
  • 5Zhang Z,Lu H,Huan F,Meghan C,Yang X,Wang Y,et al.Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1[J].Int J Cancer,2014,134(7):1539-1548.
  • 6Liu T,Hong Y,Li Z,Hong J,Zeng S,Zheng M,et al.An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population[J].Drug Metab Dispos,2012,40(5):847-851.
  • 7Zhang X,Su T,Zhang QY,Gu J,Caggana M,Li H,et al.Genetic polymorphisms of the human CYP2A13gene:identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant[J].J Pharmacol Exp Ther,2002,302(2):416-423.
  • 8Wang SL,He XY,Shen J,Wang JS,Hong JY.The missense genetic polymorphisms of human CYP2A13:functional significance in carcinogen activation and identification of a null allelic variant[J].Toxicol Sci,2006,94(1):38-45.
  • 9Goeger DE,Hsie AW,Anderson KE.Co-mutagenicity of coumarin(1,2-benzopyrone)with aflatoxin B1and human liver S9 in mammalian cells[J].Food Chem Toxicol,1999,37(6):581-589.
  • 10Reil y D,Mil er L,Luckow V.Baculovirus ExpressionVectors:A Laboratory Manual[M].New York:Oxford University Press,1994:133-134.

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部